Premium
P1‐332: Investigation of GSK‐3 alpha and GSK‐3 beta phosphorylation of tau in primary neuronal cultures and neuroblastoma cells
Author(s) -
Bose Suchira,
Cavallini Annalisa,
Glover Sarah,
Bell Amanda,
Sargent Samantha,
Angers Rachel,
Lakics Viktor,
Davies Peter,
Hutton Michael,
Szekeres Philip
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.885
Subject(s) - gsk 3 , phosphorylation , biology , gsk3b , tau protein , kinase , gene knockdown , beta (programming language) , alpha (finance) , microbiology and biotechnology , signal transduction , neurodegeneration , neuroblastoma , alzheimer's disease , cell culture , biochemistry , gene , medicine , genetics , disease , construct validity , computer science , programming language , nursing , patient satisfaction
P1-332 INVESTIGATION OF GSK-3 ALPHA AND GSK-3 BETA PHOSPHORYLATION OF TAU IN PRIMARY NEURONAL CULTURES AND NEUROBLASTOMA CELLS Suchira Bose, Annalisa Cavallini, Sarah Glover, Amanda Bell, Samantha Sargent, Rachel Angers, Viktor Lakics, Peter Davies, Michael Hutton, Philip Szekeres, Eli Lilly & Co Ltd, Windlesham, Surrey, United Kingdom; MRC Laboratory of Molecular Biology, Cambridge, United Kingdom; AECOM, The Feinstein Institute for Medical Research, Manhasset, NY, USA. Contact e-mail: bose_suchira@lilly.com